Home

Pratik S Multani

CIK 1586894 · Chief Medical Officer · last filed 2026-06-29

Pratik S Multani is a Chief Medical Officer who has filed 39 SEC Form 4 insider transactions across 5 companies since 2014. The most recent filing, for ERAS, was dated Jun 29, 2026. Across all open-market trades the lifetime net is −$130.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.57M

Companies

5

Total Filings

39

Lifetime Open-Market Net

-$130.2K

Filer Profile

Reported Address
C/O FATE THERAPEUTICS, INC.
3535 GENERAL ATOMICS COURT, SUITE 200
SAN DIEGO, CA 92121
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ERAS Director 172,866 $15.88 $2.75M $99.2K 9 2026-06-29
ORIC Chief Medical Officer 68,149 $12.04 $820.5K -$229.4K 13 2026-01-06
CHIMERIX INC (CMRX) Delisted Director — $8.54 — $0 7 2025-04-21
Ignyta, Inc. (RXDX) Delisted Chief Medical Officer 74,134 $199.92 $14.82M $0 5 2018-01-05
FATE Chief Medical Officer 3,024 $2.31 $7.0K $0 2 2015-01-07

Recent Filings

39 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-29 ERAS Grant (A) — $0 EDGAR
2026-01-06 ORIC Grant (A) — $0 EDGAR
2026-01-05 ERAS Grant (A) — $0 EDGAR
2025-12-17 ORIC Mixed +18,613 -$97.1K EDGAR
2025-12-16 ORIC Notice (144) −10,720 -$97.1K EDGAR
2025-06-26 ERAS Grant (A) — $0 EDGAR
2025-06-03 ERAS Gift (G) — $0 EDGAR
2025-04-21 CHIMERIX INC (CMRX) Delisted Disp (D) — $0 EDGAR
2025-01-03 ORIC Grant (A) — $0 EDGAR
2024-12-17 ORIC Mixed +15,192 -$73.3K EDGAR
Showing 1–10 of 39
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.